loading

Anixa Biosciences Inc Azioni (ANIX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 0.21 - -
Research and Development
14.82%
1.322
1.552 1.476 1.925 1.646
Costs And Expenses
11.31%
3.003
3.386 3.163 3.592 3.467
Operating Income/Loss
11.31%
-3.003
-3.386 -3.163 -3.592 -3.467
Income/Loss From Continuing Operations Before Tax
12.45%
-2.813
-3.213 -2.913 -3.315 -3.18
Income/Loss From Continuing Operations After Tax
12.45%
-2.813
-3.213 -2.913 -3.315 -3.18
Net Income/Loss
12.45%
-2.813
-3.213 -2.913 -3.315 -3.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
20.69%
-0.023
-0.029 -0.03 -0.038 -0.041
Basic Average Shares
0.02%
32.20
32.20 0.000094 0.0321 0.0319
Diluted Average Shares
0.02%
32.20
32.20 0.000094 0.0321 0.0319
Basic Earnings Per Share
10.00%
-0.09
-0.10 -0.09 -0.10 -0.10
Diluted Earnings Per Share
10.00%
-0.09
-0.10 -0.09 -0.10 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.58
price down icon 1.59%
$86.42
price up icon 0.06%
$27.34
price down icon 0.85%
$108.26
price down icon 2.97%
$146.15
price up icon 0.66%
biotechnology ONC
$342.21
price up icon 0.16%
Capitalizzazione:     |  Volume (24 ore):